Abstract
Background
Infectious etiologies of lower respiratory tract infections (LRTIs) by the conventional microbiology tests (CMTs) can be challenging. Metagenomic next-generation sequencing (mNGS) has great potential in clinical use for its comprehensiveness in identifying pathogens, particularly those difficult-to-culture organisms.
Methods
We analyzed a total of 205 clinical samples from 201 patients with suspected LRTIs using mNGS in parallel with CMTs. mNGS results were used to guide treatment adjustments for patients who had negative CMT results. The efficacy of treatment was subsequently evaluated in these patients.
Results
mNGS-detected microorganisms in 91.7% (188/205) of the clinical samples, whereas CMTs demonstrated a lower detection rate, identifying microorganisms in only 37.6% (77/205) of samples. Compared to CMT results, mNGS exhibited a detection sensitivity of 93.5% and 95.4% in all 205 clinical samples and 180 bronchoalveolar lavage fluid (BALF) samples, respectively. A total of 114 patients (114/201; 56.7%) showed negative CMT results, among which 92 received treatment adjustments guided by their positive mNGS results. Notably, 67.4% (62/92) of patients demonstrated effective treatment, while 25% (23/92) experienced a stabilized condition. Subgroup analysis of cancer patients revealed that 41.9% (13/31) exhibited an effective response to treatment, and 35.5% (11/31) maintained a stable condition following medication adjustments guided by mNGS.
Conclusion
mNGS demonstrated great potential in identifying microorganisms of clinical significance in LRTIs. The rapid turnaround time and reduced susceptibility to the impact of antimicrobial administration make mNGS a valuable supplementary tool for diagnosis and treatment decision-making for suspected LRTIs in clinical practice.
Similar content being viewed by others
Data availability
All sequence reads were deposited into the NCBI Sequence Read Archive (SRA) database under the accession number PRJNA952317. All the other relevant data of the study are available from the corresponding authors upon reasonable request.
Abbreviations
- LRTIs:
-
Lower respiratory tract infections
- CMT:
-
Conventional microbiological test
- mNGS:
-
Metagenomic next-generation sequencing
- BALF:
-
Bronchoalveolar lavage fluid
- PSI:
-
Pneumonia severity index
- NTC:
-
No-template control
References
Collaborators GL. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17:1133–61.
Feldman C, Shaddock E. Epidemiology of lower respiratory tract infections in adults. Expert Rev Respir Med. 2019;13:63–77.
Greene G, Hood K, Little P, Verheij T, Goossens H, Coenen S, Butler CC. Towards clinical definitions of lower respiratory tract infection (LRTI) for research and primary care practice in Europe: an international consensus study. Prim Care Respir J. 2011;20:299–306.
Korppi M, Heikkila P, Palmu S, Huhtala H, Csonka P. Antibiotic prescriptions for children with lower respiratory tract infections fell from 2014 to 2020, but misuse was still an issue. Acta Paediatr. 2022;111:1230–7.
Wei Gu SM, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol Mech Dis. 2019;14:319–38.
Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014;345(6202):1369–72.
Salipante SJ, SenGupta DJ, Cummings LA, Land TA, Hoogestraat DR, Cookson BT. Application of whole-genome sequencing for bacterial strain typing in molecular epidemiology. J Clin Microbiol. 2015;53:1072–9.
Sahoo MK, Lefterova MI, Yamamoto F, Waggoner JJ, Chou S, Holmes SP, et al. Detection of cytomegalovirus drug resistance mutations by next-generation sequencing. J Clin Microbiol. 2013;51:3700–10.
Chen H, Yin Y, Gao H, Guo Y, Dong Z, Wang X, et al. Clinical Utility of In-house Metagenomic Next-generation Sequencing for the Diagnosis of Lower Respiratory Tract Infections and Analysis of the Host Immune Response. Clin Infect Dis. 2020;71:S416–26.
Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med. 2019;380:2327–40.
Xing XW, Zhang JT, Ma YB, He MW, Yao GE, Wang W, et al. Metagenomic next-generation sequencing for diagnosis of infectious encephalitis and meningitis: a large, prospective case series of 213 patients. Front Cell Infect Microbiol. 2020;10:88.
Cao B, Huang Y, She DY, Cheng QJ, Fan H, Tian XL, et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society Chinese Medical Association. Clin Respir J. 2018;12:1320–60.
Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377–82.
Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–50.
Xu J, Zhou P, Liu J, Zhao L, Fu H, Han Q, et al. Utilizing metagenomic next-generation sequencing (mNGS) for rapid pathogen identification and to inform clinical decision-making: results from a large real-world cohort. Infect Dis Ther. 2023. https://doi.org/10.1007/s40121-023-00790-5.
Whyte JD. Advances in Flavivirus research applications: new techniques using the FastPrep-24 5G™ sample preparation system. Nat Methods. 2016;13:i–iii.
Jiang H, Xing Z, Liu X, Chai Q, Xin Z, Zhu C, et al. Comparison and development of a metagenomic next-generation sequencing protocol for combined detection of DNA and RNA pathogens in cerebrospinal fluid. BMC Infect Dis. 2022;22:326.
Li Y, Yao XW, Tang L, Dong WJ, Lan TL, Fan J, et al. Diagnostic efficiency of metagenomic next-generation sequencing for suspected spinal tuberculosis in China: A multicenter prospective study. Front Microbiol. 2022;13:1018938.
Xiao Q, Lu W, Kong X, Shao YW, Hu Y, Wang A, et al. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: a proof-of-concept study. Cancer Lett. 2021;499:201–8.
Zeng X, Wu J, Li X, Xiong W, Tang L, Li X, et al. Application of metagenomic next-generation sequencing in the etiological diagnosis of infective endocarditis during the perioperative period of cardiac surgery: a prospective cohort study. Front Cardiovasc Med. 2022;9:811492.
Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357–9.
Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20:257.
Qian L, Shi Y, Li F, Wang Y, Ma M, Zhang Y, et al. Metagenomic next-generation sequencing of cerebrospinal fluid for the diagnosis of external ventricular and lumbar drainage-associated ventriculitis and meningitis. Front Microbiol. 2020;11: 596175.
Liu L, Sun B, Ying W, Liu D, Wang Y, Sun J, et al. Rapid diagnosis of Talaromyces marneffei infection by metagenomic next-generation sequencing technology in a Chinese cohort of inborn errors of immunity. Front Cell Infect Microbiol. 2022;12: 987692.
Kunst H, Mack D, Kon OM, Banerjee AK, Chiodini P, Grant A. Parasitic infections of the lung: a guide for the respiratory physician. Thorax. 2011;66:528–36.
Song P, Li H, Liu T, Liu Y, Ma X, Su L. Disseminated strongyloidiasis misdiagnosed as guillain-barre syndrome: the value of high-throughput genetic sequencing of pathogenic microorganisms in parasitic infections. Infect Drug Resist. 2022;15:5601–7.
Chrastek D, Hickman S, Sitaranjan D, Vokshi I, Kakisi O, Kadlec J, et al. Streptococcus constellatus causing empyema and sepsis, necessitating early surgical decortication. Case Rep Infect Dis. 2020;2020:4630809.
Pendleton KM, Huffnagle GB, Dickson RP. The significance of Candida in the human respiratory tract: our evolving understanding. Pathog Dis. 2017. https://doi.org/10.1093/femspd/ftx029.
Azoulay E, Timsit JF, Tafflet M, de Lassence A, Darmon M, Zahar JR, et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest. 2006;129:110–7.
Schlaberg R, Chiu CY, Miller S, Procop GW, Weinstock G, Professional Practice C, et al. Validation of metagenomic next-generation sequencing tests for universal pathogen detection. Arch Pathol Lab Med. 2017;141(6):776–86.
Ewig S, Torres A, Angeles Marcos M, Angrill J, Rano A, de Roux A, et al. Factors associated with unknown aetiology in patients with community-acquired pneumonia. Eur Respir J. 2002;20:1254–62.
van Gageldonk-Lafeber AB, Heijnen ML, Bartelds AI, Peters MF, van der Plas SM, Wilbrink B. A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clin Infect Dis. 2005;41:490–7.
Zhang D, Yang D, Makam AN. Utility of Blood Cultures in Pneumonia. Am J Med. 2019;132:1233–8.
Miao Q, Ma Y, Wang Q, Pan J, Zhang Y, Jin W, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis. 2018;67:S231–40.
Charalampous T, Kay GL, Richardson H, Aydin A, Baldan R, Jeanes C, et al. Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection. Nat Biotechnol. 2019;37:783–92.
Wang J, Han Y, Feng J. Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis. BMC Pulm Med. 2019;19:252.
Zhang P, Chen Y, Li S, Li C, Zhang S, Zheng W, et al. Metagenomic next-generation sequencing for the clinical diagnosis and prognosis of acute respiratory distress syndrome caused by severe pneumonia: a retrospective study. PeerJ. 2020;8: e9623.
Zhou H, Larkin PMK, Zhao D, Ma Q, Yao Y, Wu X, et al. Clinical impact of metagenomic next-generation sequencing of bronchoalveolar lavage in the diagnosis and management of pneumonia: a multicenter prospective observational study. J Mol Diagn. 2021;23:1259–68.
Ge M, Gan M, Yan K, Xiao F, Yang L, Wu B, et al. Combining metagenomic sequencing with whole exome sequencing to optimize clinical strategies in neonates with a suspected central nervous system infection. Front Cell Infect Microbiol. 2021;11: 671109.
Li J, Zhang Y, Zhang Q, Lu S, Huang F, Wang J. Application of metagenomic next-generation sequencing for the diagnosis of intracranial infection of Listeria monocytogenes. Ann Transl Med. 2022;10:672.
Al-Hilu SA, Al-Shujairi WH. Dual role of bacteria in carcinoma: stimulation and inhibition. Int J Microbiol. 2020;2020:4639761.
Mao Q, Ma W, Wang Z, Liang Y, Zhang T, Yang Y, et al. Differential flora in the microenvironment of lung tumor and paired adjacent normal tissues. Carcinogenesis. 2020;41:1094–103.
Jin J, Gan Y, Liu H, Wang Z, Yuan J, Deng T, et al. Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validation. Lung Cancer. 2019;136:129–35.
Acknowledgements
The authors would like to thank the patients, their families, and the investigators and research staff involved.
Funding
Not available.
Author information
Authors and Affiliations
Contributions
TFL, QZ, and JL designed this study. TFL, QZ, and JL performed the data acquisition. TFL, QZ, JL, SW, and WWW performed data analysis. TFL, QZ, JL, SW, MMH, and QXO edited the manuscript. YQZ supervised the present study. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
JL, SW, WWW, MMH, and QXO are employees of Dinfectome Inc. The remaining authors declare no conflict of interests.
Ethical approval and consent to participate
The study was approved by the Ethics Committee of Jinling Hospital (2022DZGZR-114). Written informed consent was obtained from each patient before sample collection.
Consent for publication
Not applicable.
Supplementary Information
Below is the link to the electronic supplementary material.
15010_2024_2185_MOESM1_ESM.eps
Supplementary file1 Figure S1. Pathogens detected by mNGS but not CMTs. The y-axis represents species detected by mNGS in CMT-negative samples, whereas the x-axis represents the number of samples with the indicated species (EPS 2064 KB)
15010_2024_2185_MOESM2_ESM.eps
Supplementary file2 Figure S2. Flowchart of cancer patient inclusion for evaluating mNGS-directed treatment adjustment outcomes. 31 out of 39 mNGS-positive cancer patients showing inconsistent results with CMTs were included in the following evaluation of mNGS-directed treatment adjustment outcomes. CMT-negative but mNGS-positive patients and those without typical clinical symptoms supporting CMT diagnosis received treatments based primarily on mNGS results. Four CMT-positive patients remained on CMT-directed treatments for their clinical presentation supportive of CMT diagnosis (EPS 1692 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lv, T., Zhao, Q., Liu, J. et al. Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice. Infection 52, 625–636 (2024). https://doi.org/10.1007/s15010-024-02185-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-024-02185-1